Abstract:Esophageal carcinoma (EC) is one of the most common digestive tract malignancies, and is the sixth most common cause of cancer death worldwide1,2. EC has the two major histological types, including squamous cell carcinoma and adenocarcinoma3. Especially in China, esophageal squamous cell carcinoma (ESCC) is the major histological type4. Although significant improvement has been achieved in surgical techniques and adjuvant treatment, the clinical prognosis of ESCC remains very poor due to early lymph node metastasis and invasion of neighboring organs5. Recent years, many research focused on the pathogenesis of ESCC. However, the underlying mechanisms of the tumorigenesis and metastasis of ESCC remain largely unclear. Deeper investigation of the molecular mechanism on progression of ESCC was important to explore new biomarkers for the prognosis and treatment of ESCC. MicroRNA (miRNA) is a novel class of short, endogenous, non-coding RNA with 18-25 nucleotides in length6. Mature miRNAs negatively regulate their target genes through imperfect comAbstract. – OBJECTIVE: The aim of the current study was to elucidate the role of miR-4553p in the pathogenesis of esophageal squamous cell carcinoma (ESCC) and its prognostic value in patients with ESCC. PATIENTS AND METHODS: Expression levels of miR-455-3p and FAM83F mRNA in ESCC tissues and adjacent normal tissues were detected by quantitative RT-PCR. The X2-test was used to assess miR-455-3p expression on clinicopathological parameters. The association with overall survival of patients was analyzed by Kaplan-Meier survival analysis. Cox’s multivariate regression model was performed to identify independent prognostic factors of overall survival. The effect of miR-455-3p on proliferation was evaluated by kit-8 (CCK-8), and cell invasion was evaluated by transwell assays. The molecular target of miR-455-3p was identified using a computer algorithm and confirmed experimentally. Furthermore, the effect of miR-455-3p up-regulation on FAM83F expression was examined by Western blot. RESULTS: miRNA-455-3p was significantly increased in ESCC tissues and cell lines. Also, miR-455-3p expression was significantly associated with histological grade, lymph nodes metastasis and clinical stage (all p < 0.05). The patients with low miR-455-3p expression had shorter survival time than those with high miR455-3p expression. Furthermore, univariate and multivariate analysis identified low miR-455-3p expression as an unfavorable prognostic factor for overall survival. Moreover, transfection with the miR-455-3p mimic enhanced the cell proliferation and invasion in ESCC cells. Luciferase reporter assays confirmed that miR-455-3p binding to the 3’-UTR regions of FAM83F inhibited the expression of FAM83F in ESCC cells. Western blot confirmed that overexpression of miR455-3p resulted in down-regulation of FAM83F in ESCC cells. European Review for Medical and Pharmacological Sciences 2017; 21: 3200-3206

Prognostic Significance of FAM3C in Esophageal Squamous Cell Carcinoma

FAM3B Promotes Progression of Oesophageal Carcinoma Via Regulating the AKT–MDM2–p53 Signalling Axis and the Epithelial‐mesenchymal Transition

Overexpression of FAM3C is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma.

MiR-455-3 p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM 83 F

Overexpression of FAM3C Protein As a Novel Biomarker for Epithelial-Mesenchymal Transition and Poor Outcome in Gastric Cancer.

Increased Expression of HMGB 3 : a Novel Independent Prognostic Marker of Worse Outcome in Patients with Esophageal Squamous Cell Carcinoma

FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis

High P53 and MAP1 Light Chain 3A Co-Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

TSTA3 Facilitates Esophageal Squamous Cell Carcinoma Progression Through Regulating Fucosylation of LAMP2 and ERBB2

Up-regulation of EIF3e is Associated with the Progression of Esophageal Squamous Cell Carcinoma and Poor Prognosis in Patients.

Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.

High Expression Of Lamp3 Is A Novel Biomarker Of Poor Prognosis In Patients With Esophageal Squamous Cell Carcinoma

FAM3D regulation of head and neck squamous cell carcinoma behaviour through the EMT pathway

FAM136A as a Diagnostic Biomarker in Esophageal Cancer: Insights into Immune Infiltration, m6A Modification, Alternative Splicing, Cuproptosis, and the ceRNA Network

Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.

Association and prognostic significance of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression in esophageal squamous cell carcinoma

Identification of a three-gene prognostic signature for radioresistant esophageal squamous cell carcinoma

Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma

LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis

Family with Sequence Similarity 83, Member A (FAM83A) As a Promising Prognostic Biomarker in Lung Squamous Cell Cancer

FAM83D promotes the progression of 4NQO-induced esophageal carcinoma via inhibiting FBWX7